167 related articles for article (PubMed ID: 35939834)
1. Blood Reflux Through a PreserFlo MicroShunt Device After Needling.
Cassottana P; Di Mola I; Ferro Desideri L; Vagge A; Cutolo CA; Traverso CE; Iester M
J Glaucoma; 2022 Dec; 31(12):979-981. PubMed ID: 35939834
[TBL] [Abstract][Full Text] [Related]
2. A case of endophthalmitis following needling procedure after PRESERFLO
Brambati M; Bettin P; Ramoni A; Battista M; Bandello F
Eur J Ophthalmol; 2022 May; 32(3):NP83-NP86. PubMed ID: 34015943
[TBL] [Abstract][Full Text] [Related]
3. A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy.
Micheletti E; Riva I; Bruttini C; Quaranta L
J Glaucoma; 2020 Aug; 29(8):e87-e90. PubMed ID: 32568812
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma.
Strzalkowska A; Strzalkowski P; Hoffmann EM; Pfeiffer N; Schuster AK
J Glaucoma; 2023 Aug; 32(8):681-685. PubMed ID: 37327469
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study.
Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L
Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904
[TBL] [Abstract][Full Text] [Related]
6. Dislocation of the PreserFlo MicroShunt During a Postsurgical Needling Procedure.
Murakami K; Iida M; Shimada A; Ichioka S; Harano A; Tsutsui A; Tanito M
Cureus; 2023 Oct; 15(10):e47356. PubMed ID: 38022219
[TBL] [Abstract][Full Text] [Related]
7. Inter-eye relationship of intraocular pressure change after unilateral trabeculectomy, filtering canaloplasty, or PreserFlo™ microshunt implantation.
Aghayeva FA; Chronopoulos P; Schuster AK; Pfeiffer N; Hoffmann EM
Graefes Arch Clin Exp Ophthalmol; 2021 Oct; 259(10):3045-3053. PubMed ID: 33963917
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of the Preserflo
Majoulet A; Scemla B; Hamard P; Brasnu E; Hage A; Baudouin C; Labbé A
J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498660
[No Abstract] [Full Text] [Related]
9. Results From a Modified Bleb Needling Procedure With Continuous Infusion Performed in the Operating Room.
Wilson ME; Gupta P; Tran KV; Arora KS; Lee CH; Chang DS; Friedman DS
J Glaucoma; 2016 Sep; 25(9):720-6. PubMed ID: 27552502
[TBL] [Abstract][Full Text] [Related]
10. Comparison between Surgical Techniques Used for Revision of the Filter Bleb: A Randomized Controlled Clinical Trial.
Zantut F; P B Gracitelli C; Teixeira SH; Paranhos A
Ophthalmic Res; 2023; 66(1):1006-1013. PubMed ID: 37285822
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative primary partial occlusion of the PreserFlo MicroShunt to prevent initial postoperative hypotony.
Lüke JN; Reinking N; Dietlein TS; Haendel A; Enders P; Lappas A
Int Ophthalmol; 2023 Aug; 43(8):2643-2651. PubMed ID: 36905460
[TBL] [Abstract][Full Text] [Related]
12. Iris Obstruction Following PRESERFLO Microshunt Implantation and Surgical Management.
Trigaux C; Steindor FA; Spaniol K; Geerling G; Borrelli M
J Glaucoma; 2022 Aug; 31(8):e72-e74. PubMed ID: 35513896
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study.
Midha N; Gillmann K; Chaudhary A; Mermoud A; Mansouri K
J Glaucoma; 2020 Jan; 29(1):11-14. PubMed ID: 31702711
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of PreserFlo
Quaranta L; Micheletti E; Carassa R; Bruttini C; Fausto R; Katsanos A; Riva I
Adv Ther; 2021 Aug; 38(8):4403-4412. PubMed ID: 34251652
[TBL] [Abstract][Full Text] [Related]
15. Early Complications and Results of Preserflo MicroShunt in the Management of Uncontrolled Open-Angle Glaucoma: A Case Series.
Saeed E; Zalewska R; Konopińska J
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886531
[TBL] [Abstract][Full Text] [Related]
16. Intraocular Pressure-Lowering Effects of Trabeculectomy Versus MicroShunt Insertion in Rabbit Eyes.
Fujimoto T; Nakashima KI; Watanabe-Kitamura F; Watanabe T; Nakamura K; Maki K; Shimazaki A; Kato M; Tanihara H; Inoue T
Transl Vis Sci Technol; 2021 Aug; 10(9):9. PubMed ID: 34357381
[TBL] [Abstract][Full Text] [Related]
17. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study.
Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M
Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358
[TBL] [Abstract][Full Text] [Related]
18. XEN
Scheres LMJ; Kujovic-Aleksov S; Ramdas WD; de Crom RMPC; Roelofs LCG; Berendschot TTJM; Webers CAB; Beckers HJM
Acta Ophthalmol; 2021 May; 99(3):e433-e440. PubMed ID: 32909682
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Ibarz Barberá M; Martínez-Galdón F; Caballero-Magro E; Rodríguez-Piñero M; Tañá-Rivero P
J Glaucoma; 2022 Jul; 31(7):557-566. PubMed ID: 35583510
[TBL] [Abstract][Full Text] [Related]
20. PreserFlo MicroShunt® exposure: a case series.
Bunod R; Robin M; Buffault J; Keilani C; Labbé A; Baudouin C
BMC Ophthalmol; 2021 Jul; 21(1):273. PubMed ID: 34246229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
